跳至主要内容
临床试验/EUCTR2006-005275-18-DE
EUCTR2006-005275-18-DE进行中(未招募)不适用

Therapy-optimizing pilot study to investigate the efficacy and safety of an induction therapy with Campath-1H in combination with Tacrolimus for prevention of acute and chronic rejection in patients after primary orthotopic heart transplantation - Heart Cam & Tam

Astellas0 个研究点目标入组 10 人开始时间: 2007年12月17日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Astellas
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients > 18 years
  • Patients must have been fully informed about the study and have given
  • written informed consent prior to study participation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Pregnant or nursing women
  • Multi-organ transplant recipients
  • Previous treatment with Campath-1H
  • Use of other investigational agents within 6 weeks
  • Active systemic infection
  • HIV positive patient or donor
  • Past history of anaphylaxis following exposure to humanized monoclonal

研究者

发起方
Astellas

相似试验